Two Sigma Advisers’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $24.7M | Buy |
2,840,011
+5,600
| +0.2% | +$48.8K | 0.05% | 296 |
|
2025
Q1 | $22.6M | Buy |
2,834,411
+575,700
| +25% | +$4.58M | 0.05% | 308 |
|
2024
Q4 | $20.5M | Buy |
2,258,711
+1,537,094
| +213% | +$14M | 0.05% | 304 |
|
2024
Q3 | $6.62M | Sell |
721,617
-401,000
| -36% | -$3.68M | 0.02% | 614 |
|
2024
Q2 | $11M | Sell |
1,122,617
-654,200
| -37% | -$6.4M | 0.02% | 510 |
|
2024
Q1 | $26.8M | Buy |
1,776,817
+1,577,833
| +793% | +$23.8M | 0.06% | 282 |
|
2023
Q4 | $4.29M | Buy |
198,984
+95,386
| +92% | +$2.06M | 0.01% | 885 |
|
2023
Q3 | $1.93M | Sell |
103,598
-1,338,713
| -93% | -$24.9M | ﹤0.01% | 1230 |
|
2023
Q2 | $36.5M | Sell |
1,442,311
-717,700
| -33% | -$18.2M | 0.09% | 216 |
|
2023
Q1 | $55.9M | Buy |
2,160,011
+590,600
| +38% | +$15.3M | 0.14% | 153 |
|
2022
Q4 | $37.1M | Sell |
1,569,411
-92,300
| -6% | -$2.18M | 0.1% | 199 |
|
2022
Q3 | $42.1M | Buy |
1,661,711
+528,100
| +47% | +$13.4M | 0.12% | 179 |
|
2022
Q2 | $37.6M | Buy |
+1,133,611
| New | +$37.6M | 0.11% | 202 |
|
2021
Q1 | – | Sell |
-70,626
| Closed | -$14.1M | – | 2718 |
|
2020
Q4 | $14.1M | Buy |
70,626
+33,826
| +92% | +$6.76M | 0.04% | 450 |
|
2020
Q3 | $8.07M | Sell |
36,800
-5,800
| -14% | -$1.27M | 0.02% | 602 |
|
2020
Q2 | $8.13M | Buy |
42,600
+39,100
| +1,117% | +$7.46M | 0.02% | 625 |
|
2020
Q1 | $543K | Sell |
3,500
-15,800
| -82% | -$2.45M | ﹤0.01% | 1770 |
|
2019
Q4 | $1.62M | Buy |
+19,300
| New | +$1.62M | ﹤0.01% | 1336 |
|
2018
Q4 | – | Sell |
-8,900
| Closed | -$769K | – | 2458 |
|
2018
Q3 | $769K | Buy |
+8,900
| New | +$769K | ﹤0.01% | 1615 |
|